
Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC.TO) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
BHC.TO · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD
Net cash vs debt
Cash vs Debt · Balance Sheet HealthBausch Health Companies Inc. carries a net debt position of $19.88B. Total debt ($21.21B) exceeds cash on hand ($1.32B). Bausch Health Companies Inc. cash vs debt ratio: 6% cash / 94% debt.
Cash on hand history
Annual cash on hand by year
BHC.TO cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
Bausch Health Companies Inc. (BHC.TO) cash on hand as of December 31, 2025 is $1.32B, comprising $1.32B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Bausch Health Companies Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Bausch Health Companies Inc. cash reserves or cash position.
Bausch Health Companies Inc. annual cash on hand history shows increased +12.0% in 2025: increased +12.0% in 2025. Bausch Health Companies Inc. cash reserves in 2025 reflect the company's capital allocation strategy.
Bausch Health Companies Inc. carries total debt of $21.21B against cash of $1.32B, resulting in a net debt position of -$19.88B. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
BHC.TO cash on hand · 5 questionsAs of December 31, 2025, Bausch Health Companies Inc. (BHC.TO) has $1.32B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.32B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $1.30B. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · Bausch Health Companies Inc. · Bausch Health Companies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025